Filter by Last updated date SelectAfterBeforeFrom - To Date End Date This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Results (3838) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank European Medicines Agency public statement on Leflunomide (Arava) - Severe and serious hepatic reactions 12 March 2001NewsMedicines 68th meeting of the Committee for Proprietary Medicinal Products (CPMP) 6 March 2001Press release EMEA announces appointment of new Head of Unit for Human Medicines 1 March 2001Press releaseHumanMedicines Twenty-ninth meeting of the Management Board 23 February 2001Press releaseCorporate Committee for veterinary medicinal products: 63rd meeting 15 February 2001Press releaseVeterinary Appeal procedure for Orphan Medicinal Product designation 9 February 2001Press releaseHumanRare diseases 67th meeting of the Committee for Proprietary Medicinal Products (CPMP) 31 January 2001Press release EMEA announces new CPMP chairman and vice-chairman 23 January 2001Press release CPMP members 18 January 2001Press release 9th meeting of the Committee for Orphan Medicinal Products 18 January 2001Press releaseHumanRare diseases 1 … 361 362 363 364 365 Page 365 of 384 366 367 368 369 … 384
European Medicines Agency public statement on Leflunomide (Arava) - Severe and serious hepatic reactions 12 March 2001NewsMedicines
EMEA announces appointment of new Head of Unit for Human Medicines 1 March 2001Press releaseHumanMedicines
Appeal procedure for Orphan Medicinal Product designation 9 February 2001Press releaseHumanRare diseases
9th meeting of the Committee for Orphan Medicinal Products 18 January 2001Press releaseHumanRare diseases